Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women.

[1]  T. Rönnemaa,et al.  Gut Microbiota Richness and Composition and Dietary Intake of Overweight Pregnant Women Are Related to Serum Zonulin Concentration, a Marker for Intestinal Permeability. , 2016, The Journal of nutrition.

[2]  P. Møller,et al.  Gut microbiota‐derived lipopolysaccharide uptake and trafficking to adipose tissue: implications for inflammation and obesity , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[3]  K. Nicolaides,et al.  First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation. , 2016, Metabolism: clinical and experimental.

[4]  M. Connelly,et al.  GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. , 2016, Clinica chimica acta; international journal of clinical chemistry.

[5]  S. Erkaya,et al.  Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[6]  Liam G. Fearnley,et al.  The Biomarker GlycA Is Associated with Chronic Inflammation and Predicts Long-Term Risk of Severe Infection. , 2015, Cell systems.

[7]  S. Ozanne,et al.  The effect of maternal Inflammation on foetal programming of metabolic disease , 2015, Acta physiologica.

[8]  T. Powell,et al.  Inflammation in maternal obesity and gestational diabetes mellitus. , 2015, Placenta.

[9]  M. Connelly,et al.  GlycA: A Composite Nuclear Magnetic Resonance Biomarker of Systemic Inflammation. , 2015, Clinical chemistry.

[10]  Pasi Soininen,et al.  Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. , 2015, Circulation. Cardiovascular genetics.

[11]  F. Yue,et al.  Serum zonulin is elevated in women with polycystic ovary syndrome and correlates with insulin resistance and severity of anovulation. , 2014, European journal of endocrinology.

[12]  V. Salomaa,et al.  Endotoxemia, nutrition, and cardiometabolic disorders , 2015, Acta Diabetologica.

[13]  L. Pacifico,et al.  Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease. , 2014, World journal of gastroenterology.

[14]  K. Porter,et al.  Longitudinal changes in serum proinflammatory markers across pregnancy and postpartum: effects of maternal body mass index. , 2014, Cytokine.

[15]  F. Yue,et al.  Circulating zonulin levels in newly diagnosed Chinese type 2 diabetes patients. , 2014, Diabetes research and clinical practice.

[16]  P. Ridker,et al.  A Novel Protein Glycan Biomarker and Future Cardiovascular Disease Events , 2014, Journal of the American Heart Association.

[17]  A. Maged,et al.  Comparative study between different biomarkers for early prediction of gestational diabetes mellitus , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[18]  Haitao Wen,et al.  Inflammasomes and metabolic disorders: old genes in modern diseases. , 2014, Molecular cell.

[19]  H. Uh,et al.  Total plasma N-glycome changes during pregnancy. , 2014, Journal of proteome research.

[20]  Stephen Wan,et al.  Total adiponectin, but not inflammatory markers C-reactive protein, tumor necrosis factor-α, interluekin-6 and monocyte chemoattractant protein-1, correlates with increasing glucose intolerance in pregnant Chinese–Americans , 2014, Journal of diabetes.

[21]  V. Mohan,et al.  Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes , 2014, Molecular and Cellular Biochemistry.

[22]  P. Ridker,et al.  Abstract 18807: Novel Protein Glycan Derived Biomarker is Associated With Incident Diabetes , 2013 .

[23]  J. Chudek,et al.  Gut Microbiota, Microinflammation, Metabolic Profile, and Zonulin Concentration in Obese and Normal Weight Subjects , 2013, International journal of endocrinology.

[24]  T. Henriksen,et al.  Adiposity‐related inflammation: Effects of pregnancy , 2013, Obesity.

[25]  Zhi‐hua Liu,et al.  The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: a double-center and double-blind randomized clinical trial. , 2013, The American journal of clinical nutrition.

[26]  W. Bao,et al.  Inflammatory Markers and Risk of Type 2 Diabetes , 2012, Diabetes Care.

[27]  J. Moreno-Navarrete,et al.  Circulating Zonulin, a Marker of Intestinal Permeability, Is Increased in Association with Obesity-Associated Insulin Resistance , 2012, PloS one.

[28]  R. Alfenas,et al.  Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia , 2012, British Journal of Nutrition.

[29]  R. Zakaria,et al.  Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus. , 2012, VASA. Zeitschrift fur Gefasskrankheiten.

[30]  K. Clément,et al.  Dietary factors and low-grade inflammation in relation to overweight and obesity , 2011, British Journal of Nutrition.

[31]  S. Hauguel-de Mouzon,et al.  Pregravid Obesity Associates With Increased Maternal Endotoxemia and Metabolic Inflammation , 2011, Obesity.

[32]  P. Ebeling,et al.  Decreased variation of inflammatory markers in gestational diabetes , 2011, Diabetes/metabolism research and reviews.

[33]  G. Kac,et al.  C-reactive protein and hormones but not IL-6 are associated to body mass index in first trimester of pregnancy , 2011, Archives of Gynecology and Obstetrics.

[34]  F. Bäckhed,et al.  The endocannabinoid system links gut microbiota to adipogenesis , 2010, Molecular systems biology.

[35]  S. Ghavami,et al.  Serum trypsin inhibitory capacity in normal pregnancy and gestational diabetes mellitus. , 2009, Diabetes research and clinical practice.

[36]  L. Hansson,et al.  Reference values for α1‐acid glycoprotein, α1‐antitrypsin, albumin, haptoglobin, C‐reactive protein, IgA, IgG and IgM during pregnancy , 2008, Acta obstetricia et gynecologica Scandinavica.

[37]  R. Bibiloni,et al.  Changes in Gut Microbiota Control Metabolic Endotoxemia-Induced Inflammation in High-Fat Diet–Induced Obesity and Diabetes in Mice , 2008, Diabetes.

[38]  P. Catalano,et al.  Metabolic changes in pregnancy. , 2007, Clinical obstetrics and gynecology.

[39]  Dario Iafusco,et al.  Zonulin Upregulation Is Associated With Increased Gut Permeability in Subjects With Type 1 Diabetes and Their Relatives , 2006, Diabetes.

[40]  T. Forst,et al.  High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. , 2006, Diabetes technology & therapeutics.

[41]  C. Lopes,et al.  Central obesity as a major determinant of increased high-sensitivity C-reactive protein in metabolic syndrome , 2005, International Journal of Obesity.

[42]  Ralph B D'Agostino,et al.  Trends in cardiovascular complications of diabetes. , 2004, JAMA.

[43]  Paul M Ridker,et al.  C-Reactive Protein: A Simple Test to Help Predict Risk of Heart Attack and Stroke , 2003, Circulation.

[44]  B. Zinman,et al.  C-reactive protein and gestational diabetes: the central role of maternal obesity. , 2003, The Journal of clinical endocrinology and metabolism.

[45]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[46]  D A Follmann,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans , 2022 .

[47]  M. A. Lasunción,et al.  Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. , 1996, Journal of lipid research.

[48]  Y. Omori,et al.  Quantitative analysis of serum α1-acid glycoprotein levels in normal and diabetic pregnancy , 1990 .

[49]  Y. Omori,et al.  Quantitative analysis of serum alpha 1-acid glycoprotein levels in normal and diabetic pregnancy. , 1990, Diabetes research and clinical practice.

[50]  C. Chu,et al.  Plasma α1-acid glycoprotein levels in pregnancy , 1981 .

[51]  H. P. Wang,et al.  Plasma alpha 1-acid glycoprotein levels in pregnancy. , 1981, Clinica chimica acta; international journal of clinical chemistry.